Menu
Search
|

Menu

Close
X

Pfizer Inc PFE.N (New York Stock Exchange)

43.61 USD
+0.40 (+0.93%)
As of 11:15 AM EST
chart
Previous Close 43.21
Open 43.08
Volume 2,330,888
3m Avg Volume 6,252,993
Today’s High 43.67
Today’s Low 42.92
52 Week High 45.81
52 Week Low 33.20
Shares Outstanding (mil) 5,800.00
Market Capitalization (mil) 252,416.00
Forward P/E 18.15
Dividend (Yield %) 0.34 ( 3.12 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.61 Mean rating from 18 analysts

KEY STATS

Revenue (mm, USD)
FY18
39,670
FY17
52,546
FY16
52,825
FY15
48,851
EPS (USD)
FY18
1.924
FY17
1.965
FY16
1.178
FY15
1.110
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
18.15
29.34
Price to Sales (TTM)
vs sector
4.73
20.58
Price to Book (MRQ)
vs sector
3.53
4.23
Price to Cash Flow (TTM)
vs sector
12.15
21.19
Total Debt to Equity (MRQ)
vs sector
57.54
13.83
LT Debt to Equity (MRQ)
vs sector
47.19
9.93
Return on Investment (TTM)
vs sector
10.25
13.58
Return on Equity (TTM)
vs sector
21.82
15.11

EXECUTIVE LEADERSHIP

Ian Read
Executive Chairman of the Board, Since 2018
Salary: $1,956,750.00
Bonus: $2,600,000.00
Albert Bourla
Chief Executive Officer, Director, Since 2018
Salary: $1,170,000.00
Bonus: $1,260,000.00
Frank D'Amelio
Chief Financial Officer, Executive Vice President - Business Operations, Since 2010
Salary: $1,356,750.00
Bonus: $1,120,000.00
Mikael Dolsten
President - Worldwide Research and Development, Since 2010
Salary: $1,271,250.00
Bonus: $1,150,000.00
Angela Hwang
Group President - Pfizer Essential Health, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

235 E 42ND ST
NEW YORK   NY   10017-5703

Phone: +1212.5732323

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

SPONSORED STORIES